We only have this paper's title and publication details.
Read it at the sourceMechanistic study reveals that human alpha-defensins neutralize AAV2 vectors at micromolar concentrations, highlighting innate immune barriers to gene therapy.
No takes yet. Share an insight, caveat, or question.
Porter et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: